The Mount Sinai Medical Center Recognized by U.S. News and World Report in Annual “Best Hospitals” Rankings
July 16, 2013
The Mount Sinai Medical Center is prominently featured in U.S. News & World Report’s clinical specialty ranking of the nation’s most outstanding hospitals.
Mount Sinai Launches Phase III Clinical Trial of Novel, Personalized Vaccine for Newly-Diagnosed Kidney Cancer
April 17, 2013
Study will examine potential of investigational immunotherapy AGS-003 to improve survival when combined with standard kidney cancer treatment.
New Six-Gene Signature Can Predict Prostate Cancer Survival
October 9, 2012
Mount Sinai researchers have identified a six-gene model that determines prognosis in men with treatment-resistant prostate cancer.
Mount Sinai Researchers Present Studies On Treatment Trends, Myeloma Vaccine, and Predictive Models at Cancer Meeting
May 17, 2012
Access to care, vaccine, treatment trends among landmark research at the 2012 American Society of Clinical Oncology meeting.
Mount Sinai Partners with Integrated Medical Professionals to Treat Complex Urological Cases
February 8, 2012
Mount Sinai has affiliated with IMP, a practice that includes Advanced Urology Centers and Advanced Radiation Centers of New York to provide complex urological care.
Mount Sinai Partners With National Black Church Initiative to Raise Awareness of Breast and Prostate Cancer
November 12, 2010
Mount Sinai is working with the NBCI to raise awareness in the African-American community of breast and prostate cancer treatment options.
The Mount Sinai Medical Center Names New Vice-Chair of Department of Urology
October 15, 2010
David B. Samadi, MD, chief of robotics, is named vice-chair. An expert in robotic prostate surgery, Dr. Samadi specializes in urologic cancers.